Released on: April 21, 2008, 8:36 am

Press Release Author: Rania/GTCbio

Industry: Biotech

Press Release Summary: Dr. Allee will speak on the issue of special data management
considerations for kinetics assays.

Press Release Body: MONROVIA, CA -.Dr. Chip Allee, CEO at CeuticalSoft Inc. will be
giving a presentation at GTCbio's 3rd Assay Development & Screening Technologies
Conference on June 5-6, 2008 in San Francisco, CA. Dr. Allee will speak on the issue
of special data management considerations for kinetics assays.
Regardless of throughput classification, kinetics assays generate large volumes of
data that place extraordinary demands on conventional data handling techniques. This
impacts databases, analysis techniques, process automation, data transfer burdens
and reporting requirements. Methods for adjusting to high data volume assays (HDV)
that include shoehorning existing data systems, adding parallel systems and full
replacement will be reviewed. Some discussion will touch on the applicability to
high content assay data.
GTCbio\'s 3rd Assay Development and Screening Technologies conference will provide
attendees with critical information to utilize in the discovery and development of
assays, while keeping them informed about the latest screening technologies for both
high-throughput screening and high-content screening. Topics being covered include
cell based assays, high throughput screening, high content screening, in vitro
assays and screening, novel assay and screening technologies, and target validation.


Web Site: http://gtcbio.com/Index.aspx

Contact Details: raniah hafez
434 W. Foothill Blvd.
Monrovia, CA 91016
Tel. 626 256 6405
Fax 626 256 6460
raniah@gtcbio.com